India’s Drug Regulatory Apparatus Set For ‘Big Ticket’ Changes

Also Looks Inward To Improve

L-R: Nilesh Gupta, Managing Director, Lupin; Dr Rajeev Raghuvanshi, Drugs Controller General of India and Dr Arunish Chawla, Secretary, Department of Pharmaceuticals • Source: IPA
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from India

More from Asia